Table 1.
Clinical characteristic information for the LIHC cohort (overall=363).
| Characteristics | Groups | Number |
|---|---|---|
| Age (median [IQR]) | 61.00 [52.00, 69.00] | |
| Gender (%) | Female | 118 (32.5) |
| Male | 245 (67.5) | |
| Race (%) | American Indian or Alaska native | 1 (0.3) |
| Asian | 154 (42.4) | |
| Black or African American | 17 (4.7) | |
| White | 181 (49.9) | |
| HBV/HCV infection status (%) | Yes | 151 (41.6) |
| No | 212 (58.4) | |
| Status (%) | Dead | 233 (64.2) |
| Alive | 130 (35.8) | |
| Pathologic T (%) | T1 | 179 (49.6) |
| T2 | 91 (25.2) | |
| T3 | 77 (21.3) | |
| T4 | 13 (3.6) | |
| TX | 1 (0.3) | |
| Pathologic N (%) | N0 | 248 (68.5) |
| N1 | 3 (0.8) | |
| NX | 111 (30.7) | |
| Pathologic M (%) | M0 | 262 (72.2) |
| M1 | 3 (0.8) | |
| MX | 98 (27.0) | |
| Tumor stage (%) | I | 169 (49.9) |
| II | 84 (24.8) | |
| III | 82 (24.2) | |
| IV | 4 (1.2) | |